Anavex Life Sciences Corp. (AVXL)
NASDAQ: AVXL · Real-Time Price · USD
9.31
+0.10 (1.09%)
At close: Apr 23, 2025, 4:00 PM
8.51
-0.80 (-8.59%)
Pre-market: Apr 24, 2025, 4:19 AM EDT
Anavex Life Sciences Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Anavex Life Sciences stock have an average target of 44, with a low estimate of 42 and a high estimate of 46. The average target predicts an increase of 372.61% from the current stock price of 9.31.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Anavex Life Sciences stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $46 | Strong Buy | Maintains | $46 | +394.09% | Apr 7, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $42 | Strong Buy | Reiterates | $42 | +351.13% | Apr 7, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $42 | Strong Buy | Reiterates | $42 | +351.13% | Mar 31, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $42 | Strong Buy | Reiterates | $42 | +351.13% | Feb 18, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $46 | Strong Buy | Maintains | $46 | +394.09% | Feb 12, 2025 |
Financial Forecast
Revenue This Year
n/a
from 2.02B
Revenue Next Year
n/a
EPS This Year
-0.65
from -0.52
EPS Next Year
1.35
from -0.65
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | n/a | 698.4M | 1.1B | ||
| Avg | n/a | 227.3M | 554.2M | ||
| Low | n/a | n/a | 48.0M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | 379.1% | ||
| Avg | - | - | 143.8% | ||
| Low | - | - | -78.9% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -0.64 | 5.42 | 7.91 | ||
| Avg | -0.65 | 1.35 | 3.76 | ||
| Low | -0.68 | -0.65 | -0.15 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | 487.2% | ||
| Avg | - | - | 179.5% | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.